Noninvasive follicular thyroid neoplasm with papillary-like nuclear features: a single-institutional experience in Japan

• DOI: 10.1507/endocrj.ej17-0214
• Publication Date: 2017-09-11T22:02:51Z
• Authors: Mitsuyoshi Hirokawa; Miyoko Higuchi; Ayana Suzuki; Toshitetsu Hayashi; Seiji Kuma; Akira Miyauchi
• Keywords: Adult; Aged, 80 and over; Male; Cytodiagnosis; Middle Aged; 3. Good health; Diagnosis, Differential; Adenocarcinoma, Papillary; 03 medical and health sciences; 0302 clinical medicine; Japan; Adenocarcinoma, Follicular; Humans; Female; Thyroid Neoplasms; Aged; Retrospective Studies; Ultrasonography

Noninvasive encapsulated follicular variant of papillary thyroid carcinoma (PTC) was reclassified as noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP). To date, no studies on NIFTP have been reported in Japan. This study aimed to evaluate the clinical, cytological, and pathological findings of 54 cases of NIFTP from a single center in Japan, and compare them with those in the western countries. There were no significant differences in age, sex, or tumor size between patients with NIFTP and those with invasive encapsulated follicular variant -PTC. Ultrasound investigation showed a high suspicion lesion in 6.5% of NIFTP and 44.1% of invasive encapsulated follicular variant -PTC (p<0.001). On fine needle aspiration cytology, 75.7% of NIFTP cases were reported as suspicious for malignancy or malignant. Nuclear grooves and irregular-shaped nuclei were observed in 94.6% of cases of NIFTP. Pathologically, 27.8% cases of NIFTP and 13.0% cases of invasive encapsulated follicular variant -PTC had been originally diagnosed as macrofollicular variants of PTC. There were no NIFTP cases with nodal metastasis. We concluded that NIFTP should be renounced noninvasive encapsulated follicular variant -PTC, and should be considered as a malignant tumor with exceeding indolent behavior, and lobectomy alone should be satisfactory for the diagnosis and treatment.